Log in
Enquire now
Ultima Genomics

Ultima Genomics

Ultima Genomics is a high-throughput, low-cost sequencing platform founded in 2016.

OverviewStructured DataIssuesContributors

Contents

ultimagenomics.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Healthcare
Healthcare
Medicine
Medicine
Location
California
California
United States
United States
Newark, New Jersey
Newark, New Jersey
Newark, Arkansas
Newark, Arkansas
Newark, California
Newark, California
San Francisco
San Francisco
B2X
B2B
B2B
CEO
‌
Gilad Almogy
Pitchbook URL
pitchbook.com/profiles...265435-66
Number of Employees (Ranges)
201 – 500
Number of Employees
500
Investors
aMoon Fund
aMoon Fund
‌
NachtLaw, P.C.
‌
Lightspeed
Playground Global
Playground Global
D1 Capital Partners
D1 Capital Partners
Andreessen Horowitz (a16z)
Andreessen Horowitz (a16z)
Founders Fund
Founders Fund
Khosla Ventures
Khosla Ventures
...
Founded Date
2016
Total Funding Amount (USD)
1,200,000,000
Latest Funding Round Date
June 2, 2022
Latest Funding Type
‌
Venture round

Other attributes

Company Operating Status
Active
Funding Type
‌
Venture round
Latest Funding Round Amount (USD)
600,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Ultima Genomics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.